About this trial
Nonspecific neck pain, defined as pain without a specific underlying pathology, is a common musculoskeletal disorder that affects a significant proportion of the global population. Neck pain often results in considerable discomfort and functional limitations, impacting individuals' quality of life and ability to perform daily tasks. Estimates suggest that up to 30% of adults experience neck pain annually. The condition ranks among the top causes of disability worldwide, contributing to substantial personal and societal burdens, including lost work productivity and increased healthcare costs.
Eligibility criteria
Qualifiers
unilateral or bilateral CNP
Experiencing moderate to severe neck pain, defined as a Visual Analog
Scale (VAS) score of ≥4.
Cervical Range of Motion (ROM) Limitation: Documented restriction in cervical ROM compared to normal values for age and gender, to ensure the condition's impact on functional mobility
Disqualifiers
Previous Cervical Surgery: Patients with a history of cervical spine surgery will be excluded to eliminate potential influences from post-surgical changes on the outcomes
Diagnosed with cervical disc prolapse as confirmed by clinical evaluation and imaging studies (MRI or CT scans).
History of malignancy in the cervical region or other serious medical conditions.
Severe comorbidities that may affect treatment outcomes (e.g., uncontrolled diabetes, cardiovascular diseases).
Trial design
Treatments tested in this trial
- High intensity laser therapy (low dose) combined with conventional physiotherapy program
- High intensity laser therapy (High dose) combined with conventional physiotherapy program